TP53 and breast carcinoma: AMPKα2 is significantly reduced in breast cancer tissue samples, and re-expression of AMPKα2 in the human breast cancer cell line MCF-7 inhibits xenograft growth in athymic nude mice via p53 upregulation and cyclin D1 reduction [9].